91940 ⎘
Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups; Unsaturated compounds containing hydroxy or O-metal groups
Sub-classes:SYNTHETIC PROCESS FOR PRODUCTION OF LIPOXIN B4 AND ANALOGUES THEREOF
#220-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE
#3COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF INFLAMMATORY, DEGENERATIVE, AND NEURODEGENERATIVE DISEASES
#420-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE
#5OXYLIPINS, PROCESSES FOR MAKING THE SAME, AND METHODS FOR USING THE SAME
#6FATTY ACID DERIVATIVES AND THEIR USE
#7VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS, ELOVANOID HYDROXYLATED DERIVATIVES, AND METHODS OF USE
#8PRODUCTION METHOD FOR RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID
#9Compositions and methods relating to salts of specialized pro-resolving mediators
#10METHOD FOR PRODUCING RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID
#11Fatty acid derivatives and their use
#12Compositions and methods relating to salts of specialized pro-resolving mediators
#13LINKER OF BIOPROBES
#14Molecules from seaweeds with anti-cancer activity
#15Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases
#16PHARMACEUTICALLY ACCEPTABLE SALTS OF FATTY ACIDS
#17Compositions and methods relating to salts of specialized pro-resolving mediators
#18Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections
#1920-HETE receptor (GPR75) antagonists and methods of use
#20Topical compositions comprising polyunsaturated fatty acids
#21LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE
#22Method for producing rare fatty acid using novel enzyme, and novel rare fatty acid
#23Preparation of 2,5,6-trihydroxy-3-hexenoic acid and 2,5-dihydroxy-3-pentenoic acid and esters thereof from C6 and C5 sugars
#24Hydroxyeicosatrienoic acid compounds and their use as therapeutic agents
#25Plant extract compositions for forming protective coatings
#26Elucidation of Novel 13-Series Resolvins that Increase with Atorvastatin and Clear Infections
#27Preparation of 2,5,6-trihydroxy-3-hexenoic acid and 2,5-dihydroxy-3-pentenoic acid and esters thereof from C6 and C5 sugars
#28Pharmaceutically acceptable salts of fatty acids
#29Compositions and methods relating to salts of specialized pro-resolving mediators
#30Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases
#3114-hydroxy-docosahexaenoic acid compounds
#3214-hydroxy-docosahexaenoic acid compounds
#3314-hydroxy-docosahexaenoic acid compounds
#34METHOD FOR DETECTING HYPOXIA OR DIAGNOSING HYPOXIA-RELATED DISEASES
#35Intestinal tract-protecting agent containing hydroxylated fatty acid
#36Statins of omega-3 polyunsaturated acids for treating hypercholesterolemia
#37Topical compositions comprising polyunsaturated fatty acids
#38Pharmaceutically acceptable salts of fatty acids
#39Methods of making 15-hydroxy fatty acid derivatives
#4014-hydroxy-docosahexaenoic acid compounds
#4114-hydroxy-docosahexaenoic acid compounds
#4214-hydroxy-docosahexaenoic acid compounds
#43Methods of treating amyotrophic lateral sclerosis
#44Use of PUFAS for treating skin inflammation
#45Enantiomers of 2-hydroxy derivatives of fatty acids
#46Use of pufas for treating skin inflammation
#47Use of docasatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma
#48Crystalline salts of Asenapine with organic di-acids and tri-acids
#49NITRIC OXIDE AND ITS BIOMEDICAL SIGNIFICANCE
#50Chemical and biological agents for the control of molluscs
#51Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers
#52Chemical and biological agents for the control of molluscs
#53LIPOXIN COMPOUNDS AND THEIR USE IN TREATING CELL PROLIFERATIVE DISORDERS
#54Use of docosatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma
#55Use of pufas for treating skin inflammation
#56Use of PUFAs for treating skin inflammation
#57HYDROXY FATTY ACID COMPOUNDS AND USES THEREOF FOR DISEASE TREATMENT AND DIAGNOSIS
#58Anti-inflammatory compounds
#5914-hydroxy-docosahexaenoic acid compounds
#60Hydroxy- and aldehyde functional compounds
#61OXYLIPINS FROM LONG CHAIN POLYUNSATURATED FATTY ACIDS AND METHODS OF MAKING AND USING THE SAME
#62Oxylipins From Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same
#63OXYLIPINS FROM STEARIDONIC ACID AND GAMMA-LINOLENIC ACID AND METHODS OF MAKING AND USING SAME
#64CHEMICAL AND BIOLOGICAL AGENTS FOR THE CONTROL OF MOLLUSCS
#65Aspirin-triggered lipid mediators
#66Carboxylic acid and antidepressant composition containing the same as active ingredient
#67SYNTHESIS OF RESOLVINS AND INTERMEDIATES, COMPOUNDS PREPARED THEREBY, AND USES THEREOF
#68RESOLVINS: BIOTEMPLATES FOR NOVEL THERAPEUTIC INTERVENTIONS
#69OXYLIPINS FROM STEARIDONIC ACID AND GAMMA-LINOLENIC ACID AND METHODS OF MAKING AND USING THE SAME
#70Crystalline leukotriene B
#71Lipoxin compounds and their use in treating cell proliferative disorders
#72Lipoxin compounds and their use in treating cell proliferative disorders
#73Unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof
#74Substituted pyridine ligands and related water-soluble catalysts
#75Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers
#76Aspirin-triggered lipid mediators
#77Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
#78Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives
#79Method for preparing unsaturated fatty hydroxyacids
#80PEG-Substituted Pyridine Ligands and Related Water-Soluble Catalysts
#81CERAMIDASE INHIBITOR
#82Analogues of lipid mediators derived from ω-3 PUFAs and methods of use
#83Process for the Preparation of Sulfonamide Derivatives
#84Analogs of dictyostatin, intermediates therefor and methods of systhesis thereof
#85Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
#86Modulation of Inflammation Related to Columnar Epithelia
#87Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
#88PROCESS FOR THE MANUFACTURE OF HMG-COA REDUCTASE INHIBITORY MEVALONIC ACID DERIVATIVES
#89Ceramidase inhibitor
#90Aspirin-triggered lipid mediators
#91Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
#92Phenoxy carboxylic acid compounds and compositions for delivering active agents
#93Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
#94PEG-substituted pyridine ligands and related water-soluble catalysts
#95Cephalotaxane derivatives and their processes of preparation and purification
#96Decrease in oxidative stress status through the administration of natural products and pharmaceutical drugs
#97Methylidene mevalonates and their use as herbicides
#98Lipoxin compounds and their use in treating cell proliferative disorders
#99Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof
#100Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
#101Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives
#102Lipoxin compounds and their use in treating cell proliferative disorders
#103Cephalotaxane derivatives and their processes of preparation and purification
#104Hydroxyeicosenoic acid anaglogs
#105Hydroxyfattysulfonic acid analogs
#106Polyene polyketides, processes for their production and their use as pharmaceuticals